Pediatric Open-Label Extension Study
clinical trial
Press Enter · cited answer in seconds
0 sources
Pediatric Open-Label Extension Study
Summary
Pediatric Open-Label Extension Study is a clinical trial[1].
Key Facts
- Pediatric Open-Label Extension Study is located in Puerto Rico[2].
- Pediatric Open-Label Extension Study is in the country of Bulgaria[3].
- Pediatric Open-Label Extension Study is in the country of Colombia[4].
- Pediatric Open-Label Extension Study is in the country of France[5].
- Pediatric Open-Label Extension Study is in the country of Hungary[6].
- Pediatric Open-Label Extension Study is in the country of Malaysia[7].
- Pediatric Open-Label Extension Study is in the country of Mexico[8].
- Pediatric Open-Label Extension Study's instance of is recorded as clinical trial[9].
- Pediatric Open-Label Extension Study's start time is recorded as +2013-09-30T00:00:00Z[10].
- Pediatric Open-Label Extension Study's end time is recorded as +2018-10-17T00:00:00Z[11].
- Pediatric Open-Label Extension Study's main subject is recorded as bipolar disorder[12].
- Pediatric Open-Label Extension Study's main subject is recorded as schizophrenia[13].
- Pediatric Open-Label Extension Study's number of participants is recorded as {'unit': '1', 'amount': '+702'}[14].
- Pediatric Open-Label Extension Study's title is recorded as A 104-Week, Flexible-Dose, Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Effectiveness of Lurasidone in Pediatric Subjects[15].
- Pediatric Open-Label Extension Study's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+6'}[16].
- Pediatric Open-Label Extension Study's ClinicalTrials.gov ID is recorded as NCT01914393[17].
- Pediatric Open-Label Extension Study's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+17'}[18].
- Pediatric Open-Label Extension Study's research intervention is recorded as lurasidone hydrochloride[19].
- Pediatric Open-Label Extension Study's clinical trial phase is recorded as phase III clinical trial[20].
- Pediatric Open-Label Extension Study's research site is recorded as University of South Florida[21].
- Pediatric Open-Label Extension Study's research site is recorded as Atlanta Center for Medical Research[22].
- Pediatric Open-Label Extension Study's research site is recorded as University of Kentucky[23].
- Pediatric Open-Label Extension Study's research site is recorded as Jersey Shore University Medical Center[24].
- Pediatric Open-Label Extension Study's research site is recorded as Ohio State University[25].
- Pediatric Open-Label Extension Study's research site is recorded as University of Virginia[26].